XML 15 R7.htm IDEA: XBRL DOCUMENT v3.26.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Cash flows from operating activities:    
Net Income (Loss) $ (12,432) $ (40,178)
Adjustments to reconcile net loss to net cash provided by operating activities:    
Depreciation and amortization 11,104 13,270
Share-based compensation expense 79,204 74,854
Non-cash operating lease expense 3,981 4,273
Net amortization of premium or discount on investments (1,629) (3,031)
Losses (gains) on foreign exchange 473 (333)
Changes in operating assets and liabilities:    
Accounts receivable (15,931) 7,726
Prepaid expenses and other assets (8,467) (1,450)
Deferred contract acquisition costs (10,634) (3,105)
Accounts payable (6,069) 19
Accrued expenses and other liabilities 16,257 9,528
Operating lease liabilities (4,208) (4,342)
Deferred revenue 43,763 7,646
Net cash provided by operating activities 95,412 64,877
Cash flows from investing activities:    
Purchases of short-term investments (337,707) (284,142)
Maturities of short-term investments 238,954 200,086
Purchases of property and equipment (4,377) (1,274)
Net cash used in investing activities (103,130) (85,330)
Cash flows from financing activities:    
Proceeds from exercise of share options 4,798 6,874
Proceeds from employee share purchase plan 8,156 6,294
Proceeds from employee equity transactions, net of payments to tax authorities and employees 17,959 7,929
Repurchases of ordinary shares (2,028) 0
Net cash provided by financing activities 28,885 21,097
Effect of exchange rate changes on cash, cash equivalents and restricted cash (315) 764
Net increase in cash, cash equivalents, and restricted cash 20,852 1,408
Cash, cash equivalents, and restricted cash—beginning of period 76,551 50,627
Cash, cash equivalents, and restricted cash—end of period $ 97,403 $ 52,035